Media Centre
© Enthera. All rights reserved
Enthera Srl, Via Visconti di Modrone, 18, 20122 Milan, Italy
T: +39 02 49533580
E: info@entherapharmaceuticals.com
Enthera Srl, Via Visconti di Modrone, 18, 20122 Milan, Italy
T: +39 02 49533580
E: info@entherapharmaceuticals.com
This website uses only technical cookies and does not perform any profiling or collection of personal data through cookies. Simply browsing the website does not require the user’s consent.
Website by Instinctif Partners
BiovelocITA, the Italian biotech accelerator, launches two companies, one against diabetes, the other against cancer
/in Press ReleasesTwo research project collaborations – one in diabetes and one in oncology – have been launched, with a total investment of €2.5 million. These are the first projects launched by BiovelocITA, the Italian biotech accelerator launched last year by the chemist and entrepreneur Silvano Spinelli, Gabriella Camboni and the venture capital firm Sofinnova Partners.